Huapont Life Sciences Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 10,180.99 million compared to CNY 8,629.35 million a year ago. Revenue was CNY 10,180.99 million compared to CNY 8,629.35 million a year ago.

Net income was CNY 717.02 million compared to CNY 520.61 million a year ago. Basic earnings per share from continuing operations was CNY 0.3621 compared to CNY 0.2629 a year ago. Diluted earnings per share from continuing operations was CNY 0.3621 compared to CNY 0.2629 a year ago.